Cargando…
COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?
Autores principales: | Maier, Cheryl L, Truong, Alexander D, Auld, Sara C, Polly, Derek M, Tanksley, Christin-Lauren, Duncan, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247793/ https://www.ncbi.nlm.nih.gov/pubmed/32464112 http://dx.doi.org/10.1016/S0140-6736(20)31209-5 |
Ejemplares similares
-
Blood Hyperviscosity: A Novel Link Between Hyperinflammation and Hypercoagulability in COVID-19
por: Bonaventura, Aldo, et al.
Publicado: (2022) -
Hyperviscosity syndrome revisited
por: Gangopadhyay, Debasree, et al.
Publicado: (2022) -
Blood hyperviscosity in acute and recent COVID-19 infection
por: Shaik, Aleesha, et al.
Publicado: (2022) -
Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19
por: Joob, Beuy, et al.
Publicado: (2021)